sepharose and Shock--Septic

sepharose has been researched along with Shock--Septic* in 5 studies

Reviews

1 review(s) available for sepharose and Shock--Septic

ArticleYear
Experimental models of plasma perfusion.
    Journal of clinical apheresis, 1991, Volume: 6, Issue:2

    A system allowing repeated plasma perfusion in the unrestrained conscious rat was developed in order to examine the effects of plasma filtration with on-line sorbent treatment of plasma in various models of disease. In experimental autoimmune glomerulonephritis, perfusion over a column coated with glomerular basement membrane (GBM) antigen lowered circulating levels of anti-GBM antibodies. In experimental endotoxaemia, perfusion over a column coated with polymixin B (PB) lowered circulating endotoxin levels and protected animals from haematological abnormalities and death. In experimental acute hepatic failure, perfusion over a combination of charcoal, resin, and PB columns improved survival in grades II and III hepatic coma. This experimental system has allowed preclinical evaluation of the effectiveness of different sorbents in the treatment of a range of disorders.

    Topics: Animals; Anion Exchange Resins; Anti-Glomerular Basement Membrane Disease; Charcoal; Extracorporeal Circulation; Hemoperfusion; Hepatic Encephalopathy; Immunosorbent Techniques; Rats; Rats, Inbred BN; Rats, Inbred Strains; Resins, Synthetic; Sepharose; Shock, Septic; Sorption Detoxification

1991

Other Studies

4 other study(ies) available for sepharose and Shock--Septic

ArticleYear
Protective effect of porphyran isolated from discolored nori (Porphyra yezoensis) on lipopolysaccharide-induced endotoxin shock in mice.
    International journal of biological macromolecules, 2016, Volume: 93, Issue:Pt A

    Porphyran, a sulfated polysaccharide, isolated from discolored nori (Porphyra yezoensis) (dc-porphyran) and one fraction (F1) purified from dc-porphyran by DEAE-chromatography showed the protective effects on LPS-induced endotoxin shock in mice. Intraperitoneal (i.p.) treatment with dc-porphyran or F1 (100mg/kg) 60min prior to i.p. injection of LPS (30mg/kg) completely protected mice from LPS lethality. At 10mg/kg concentration, F1 demonstrated more protection than dc-porphyran. Intravenous (i.v.) challenge of LPS, even at 20mg/kg, was more lethal than i.p. administration; i.v. injection of F1 (100mg/kg) with LPS significantly improved the survival rate. However, i.v. dc-porphyran (100mg/kg) produced an even lower survival rate than that of LPS alone. We examined pro-inflammatory mediators such as NO and TNF-α in serum. F1 significantly reduced the levels of these markers. Additionally, F1 significantly decreased the malondialdehyde level in the liver, a marker of oxidative stress, while dc-porphyran had almost no effect. Furthermore, F1 significantly decreased the production of TNF-α and NO in peritoneal exudate cells harvested from LPS-challenged mice, while dc-porphyran treatment showed a lesser decrease. Our results suggest that porphyran isolated from discolored nori, especially F1, is capable of suppressing LPS-induced endotoxin shock in vivo.

    Topics: Animals; Color; Lipopolysaccharides; Liver; Male; Mice; Nitric Oxide; Oxidative Stress; Porphyra; Sepharose; Shock, Septic; Tumor Necrosis Factor-alpha

2016
Endotoxin removal from whole blood by a novel adsorption resin: efficiency and hemocompatibility.
    The International journal of artificial organs, 2004, Volume: 27, Issue:6

    The structural component of Gram- bacteria, endotoxin (ET), induces the release of endogenous mediators of sepsis. Attempts to remove these downstream molecules in vivo, have not improved survival. However, extracorporeal strategies such as continuous renal replacement therapy or therapeutic plasmapheresis have shown benefit. We are presenting an affinity-based extracorporeal technology for the removal of ET from whole blood. The small-scale device contains an adsorbent that removed 75% of ET present in whole blood. This affinity resin displayed good hemocompatibility regarding the coagulation pathway. Minimal platelet, neutrophil and complement activation were observed. There was also no evidence of consumption of coagulation factors or cell loss. In as much as ET participates in both the inflammatory and coagulation abnormalities in sepsis, this method represents an efficient and hemocompatible way to remove ET from whole blood, which, in an extracorporeal setting, may improve the outcome of sepsis.

    Topics: Adsorption; Anti-Infective Agents; Blood Coagulation Factors; Cell Count; Chromatography, Affinity; Complement C3a; Endotoxins; Fibrinogen; Gram-Negative Bacterial Infections; Hemostasis; Humans; Leukocyte Elastase; Ligands; Monocytes; Ofloxacin; Sepharose; Shock, Septic; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha

2004
A CO2-enhanced hemolytic activity of Staphylococcus aureus associated with toxic shock syndrome: inhibition by agar.
    The Journal of infectious diseases, 1986, Volume: 154, Issue:1

    Topics: Agar; Animals; Carbon Dioxide; Hemolytic Plaque Technique; Humans; Rabbits; Sepharose; Shock, Septic; Staphylococcus aureus

1986
The defined antigen substrate sphere system with direct immunohistoperoxidase for detection of soluble dengue antigen in sera of patients with dengue hemorrhagic fever.
    American journal of clinical pathology, 1978, Volume: 70, Issue:3

    The defined antigen substrate sphere system is a simple method for detecting antigen or antibody in the circulation. The technic is based on the coupling of antigen or antibody with Sepharose 4B beads that have been activated by cyanogen bromide. In this study the activated beads were exposed to dengue antigen in the serum from a patient with dengue hemorrhagic fever and then stained with antidengue antibody conjugated with horseradish peroxidase. The positive reaction showed brown beads by light microscopy, whereas the negative reaction gave colorless beads. The authors examined 134 specimens from 91 cases. The results were positive in 53.85%. The dengue antigen appeared in the sera on the day before shock or subsidence of fever. The percentages of sera containing soluble dengue antigen were greatest on the day of shock or subsidence of fever (33.33%) and on the fifth day of fever (28.07%). The highest titers of soluble dengue antigen (1:40 to 1:80) appeared in the sera of patients who had Grade III disease on the day of shock. The dengue antigen appeared most often in sera that had high titers of dengue antibody. It is postulated that this detected dengue antigen may be a part of soluble immune complexes formed during the hyperimmune stage of the immune response, and plays a significant role in the pathogenesis of dengue hemorrhagic fever and shock syndrome.

    Topics: Antibodies, Viral; Antigen-Antibody Complex; Antigens, Viral; Child; Child, Preschool; Dengue; Dengue Virus; Fluorescent Antibody Technique; Horseradish Peroxidase; Humans; Immunoenzyme Techniques; Infant; Sepharose; Shock, Septic

1978